🎧 The journey with
#SpinalMuscularAtrophy
(SMA) is unique for everyone, and the SMA My Way podcast is here to recognise and celebrate that.
Join us to listen to the powerful stories of our SMA My Way Champions:
We are pleased that the CHMP has issued a positive recommendation for our ALK inhibitor in the adjuvant setting – an important step toward improving treatment outcomes in early-stage disease.
$RHHBY $ROG
#RocheInnovation
#Science
#SMAMyWay
Champion, Louise, shares her experiences of growing up with
#SMA
and the transition from relying on her family to relying on personal care assistants. Read her blog here:
#SpinalMuscularAtrophy
Roche sales increase by 2% (CER) in first quarter with both divisions growing high single digit ex COVID-19. We confirm our outlook for 2024. For more details on our performance, click here ➡️
$ROG $RHHBY
#RocheFinancialResults
We are delighted that the FDA has approved our ALK inhibitor for adjuvant use for people with resected ALK-positive early-stage lung cancer, furthering our aim to provide patients with the best chance for cure.
$RHHBY $ROG
#RocheInnovation
#Science
Paulo Fontoura discusses the future of
#MultipleSclerosis
care and how the latest advancements in scientific research are helping to provide new options for people with MS in managing their condition from diagnosis:
#MEDIA
We are pleased to announce that our off-the-shelf bispecific antibody combination showed a statistically significant improvement in overall survival for people with relapsed or refractory diffuse large B-cell
#lymphoma
in a Phase III study.
$RHHBY
#MEDIA
: We are pleased to announce that
@FDA
granted Breakthrough Device Designation of our blood test to support earlier
#Alzheimer
's disease diagnosis.
Learn more here:
$ROG $RHHBY
#SMAMyWay
Champion, Louise, discusses her journey from childhood to adult care while living with spinal muscular atrophy (SMA). Hear her experience and the advice she would give her younger self.
#MEDIA
- We are pleased to announce that Roche received
@FDA
approval for the first molecular test to screen for
#malaria
in blood donors.
Read more here:
$ROG $RHHBY
Exciting news!🎉 Professor Juergen Knoblich
@Knoblich_lab
, a pioneer in
#organoids
& neurobiology, joins Roche as the Head of the Institute of Human Biology in
#Basel
. His expertise will help us accelerate drug development.
@IHB_Research
's future looks bright!
#RocheInnovation
Countless women globally confront challenges in healthcare stemming from a pervasive misunderstanding of female health. We've reached out to them, and they told us their stories. Here are the results:
#XProject
#TogetherForChange
#MyStoryForChange
Join our LinkedIn Live on the digital endpoints, on March 21st to hear the insights of Prof Jeffrey Statland from
@KUMedCenter
, Damien Eggenspieler and Paul Strijbos, Neurotech Innovation at
@Roche
. Register here:
#DigitalEndpoints
#ClinicalTrials